Profil
Jennifer Laux served as Chief Commercialization Officer at Helius Medical Technologies, Inc. from 2018 to 2019.
Prior to that, she was Vice President-Commercial Development at Inovio Pharmaceuticals, Inc. from 2013 to 2018 and Vice President-Cardiovascular Marketing at Boehringer Ingelheim Corp.
in 2012-2013.
Laux holds a graduate degree from the University of Pennsylvania and an undergraduate degree from Georgetown University.
She also earned an MBA from The Wharton School of the University of Pennsylvania.
Ehemalige bekannte Positionen von Jennifer Laux
| Unternehmen | Position | Ende |
|---|---|---|
| HELIUS MEDICAL TECHNOLOGIES, INC. | Corporate Officer/Principal | 30.08.2019 |
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2018 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01.05.2013 |
Ausbildung von Jennifer Laux
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| HELIUS MEDICAL TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
